| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 165.60▲ | 166.01▼ | 166.13▼ | 166.09▼ | 166.78▼ |
| MA10 | 165.73▲ | 166.33▼ | 166.98▼ | 165.91▼ | 167.73▼ |
| MA20 | 165.99▼ | 167.02▼ | 166.61▼ | 166.67▼ | 168.62▼ |
| MA50 | 166.86▼ | 166.12▼ | 166.18▼ | 168.08▼ | 157.91▲ |
| MA100 | 167.06▼ | 166.09▼ | 165.88▼ | 168.81▼ | 165.12▲ |
| MA200 | 166.16▼ | 166.10▼ | 166.41▼ | 162.31▲ | 151.02▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.020▲ | -0.237▼ | -0.189▼ | 0.156▲ | -0.799▼ |
| RSI | 38.612▼ | 37.160▼ | 44.142▼ | 48.048▼ | 49.692▼ |
| STOCH | 20.591 | 3.343▼ | 11.796▼ | 59.871 | 41.140 |
| WILL %R | -56.098 | -88.350▼ | -88.350▼ | -38.559 | -63.476 |
| CCI | -30.410 | -108.720▼ | -138.878▼ | 42.327 | -45.854 |
|
Sunday, November 10, 2019 05:00 AM
In partnership with Covance, the drug development arm of LabCorp (NYSE: LH), Genfit developed the test to drive the identification and diagnosis of patients that could then benefit from drug treatment ...
|
|
Wednesday, November 06, 2019 04:06 PM
John Ratliff resigned as chief executive officer of LabCorp Diagnostics (NYSE: LH) on Nov. 1, the company announced Wednesday. Ratliff’s new role had been announced less than a month earlier and was ...
|
|
Wednesday, November 06, 2019 04:02 AM
LabCorp® (NYSE: LH), a leading global life sciences company, today announced that John Ratliff is departing the company to pursue another opportunity. Dr. Brian Caveney has been named executive vice ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/11/19 | 167.89 | 167.89 | 165.46 | 165.82 | 285,365 |
| 08/11/19 | 166.22 | 168.57 | 165.53 | 168.41 | 497,400 |
| 07/11/19 | 166.31 | 167.30 | 165.01 | 165.80 | 407,500 |
| 06/11/19 | 164.42 | 165.27 | 163.66 | 165.27 | 542,200 |
| 05/11/19 | 166.10 | 167.91 | 164.31 | 165.14 | 679,963 |
| 04/11/19 | 167.35 | 167.35 | 165.14 | 166.04 | 349,169 |
| 01/11/19 | 165.79 | 167.67 | 165.48 | 166.53 | 382,900 |
| 31/10/19 | 165.89 | 166.69 | 164.08 | 164.77 | 430,100 |
| 30/10/19 | 165.38 | 166.50 | 164.54 | 166.28 | 322,800 |
| 29/10/19 | 163.96 | 165.72 | 163.60 | 165.09 | 337,900 |
|
|
||||
|
|
||||
|
|